Learn about Roger Wilson‘s story as a sarcoma patient and the founder of Sarcoma UK

EORTC – European Organisation for Research and Treatment of Cancer shared on LinkedIn:

“Roger Wilson is a sarcoma patient and the founder of Sarcoma UK one of EORTC’s funding partners of the STRASS/STREXIT 2 clinical trial.

He is also the Honorary President and an active Board member of the Sarcoma Patient Advocacy Global Network (SPAGN).

Learn more about his story and involvement in the EORTC-lead STREXIT 2 Project in this insightful interview.”

Source: EORTC/LinkedIn